RLAY
Relay TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
RLAY vs peer average
33/100
RLAY vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 1 · D 3 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ELVN is the first available peer comparator.
Enliven is another similarly sized clinical oncology peer where valuation is driven by program readouts and regulatory path, making it a reasonable comparison for binary catalyst risk rather than indication overlap.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RLAY
Relay Therapeutics
ELVN
Enliven Therapeutics
Grade
F
D
Momentum
74
17
Value
41
41
Sentiment
26
48
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ELVN
RLAY / ELVN
Grade Position
Below peers
RLAY vs. peer average (F vs. D)
33/100
Momentum
74
RLAYValue
41
RLAYSentiment
26
ELVNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RLAY
ELVN is the first peer returned for this comparison set.